Aliskiren
Canadian Agency for Drugs and Technologies in Health
Record ID 32007000068
English
Authors' objectives:
The aim of this study was to summarize the available information on the use of Aliskiren (Tekturna, formerly known as Rasilez) in the treatment of hypertension.
Authors' methods:
Overview
Details
Project Status:
Completed
URL for project:
http://www.cadth.ca/media/pdf/E0006_aliskiren_edrug_e.pdf
Year Published:
2006
URL for published report:
n/a
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Antihypertensive Agents
- Hypertension
- Amides
- Fumarates
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drug and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.